Social engagement
Social engagement: 9.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Europa, Invivo Ventures, Columbus Venture Partners, Advent France Biotechnology.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 54% |
| Private equity | 1 | 8% |
| Accelerator & incubator | 2 | 15% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 2 | 15% |
Recent activity
8 Jun 2026
Event
Oppenheimer & Co. Inc. CNS and Neuro-Muscular Summit
27 May 2026
Event
IDMC-15 - International Myotonic Dystrophy Consortium Meeting
22 Apr 2026
Event
Oligoucleotides for CNS Summit Europe